Adocia to Present New Clinical Data on BioChaperone® Technology at the 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019) Advanced Technologies & Treatments for Diabetes (ATTD 2019) “The data presentations at the ATTD Annual Meeting demonstrate the potential of our BioChaperone technology to improve diabetes care and management,” commented Dr. Olivier
Steve Daly, Adocia US General Manager, will make a Presentation during The BIO CEO & Investor Conference, one of the largest investor conferences focused on established and emerging publicly traded and and select private biotech companies. This speaker’s sessions: New Treatments for Diabetes and Obesity: Innovations for Chronic Diseases      Date: Tuesday, February 12 9:00
Pharmapack Europe Event is dedicated to pharmaceutical packaging and drug delivery. Key event in Europe to meet innovating companies in  the field of pharmaceutical packaging, labelling, drug delivery device design, engineering and more. Where: Paris Expo, Porte de Versailles, Hall 7.2 | Paris, France When: on February 6 and 7, 2019 – Paris  
Next January 28-30, 2019, ADOCIA will be attending the Drug Delivery Partnerships Event in Palm Beach Gardens (Florida, US). For 22 years, DDP has been the world’s largest drug delivery meeting place. DDP Website #DrugDelivery #NewTherapeuticAreas
Journalist Didier Testot interviewed Dr Olivier Soula, Deputy General Manager at Adocia, on key milestones achieved by the company in the past year and its outlook for 2019. You may watch the interview here: : “Adocia is not for sale”. (French only)  
BIOTECHSCOPE® 2019 Roundup of J.P. Morgan’s Annual Healthcare Conference, Paris, France. At this occasion, Gerard Soula, Adocia CEO, is invited to participate in the roundtable organised by Biotech Finances and Neighborhood, the life sciences innovation center of VCLS (Voisin Consulting Life Sciences). Registration on the website link.   Place VCLS’s Innovation Center – Neighborhood 64
Next January 5th and 6th, Adocia team will be attending the East-West CEO Conference in San Francisco. This forum is the occasion to meet global leaders in the biopharma community in order to network and share insights on the industry outlook for the coming year. 
On January 6th, Adocia will present at this conference which brings together 100+ investors and pharma leaders from China in an event designed to foster cross-border investment and collaboration.
Since 2016 and throughout four years, Adocia sponsors the 135th ESPCI Promotion (Paris). Adocia is pleased to represent an international biotechnology company dedicated to protein delivery focused on Innovation. Last November, four Adocia researchers, gratuated from ESPCI Paris, were presented Adocia services: Analysis, Chemistry, Physico-Chemistry, Biology.            
Gérard Soula, President and CEO of Adocia, interviewed by Véronique Guisquet during the French Shareholder’s Event Actionaria 2018 – “Face of the leaders”. This year, 23923 visitors went to the Palais des Congrès in Paris (France) for two business investment days: 22 and 23 November 2018. Dear visitors, it was a pleasure to meet you on